Redefining the early detection and clinical management of cancer.
Advanced Solutions for Pap Smear Preparation and Screening Available
Outside of the United States.
|
| |
BD SurePath™ liquid-based Pap test
|
 |
| Give your practice the competitive edge by choosing the unique sample collection, preservative, and processing that only BD SurePath™ liquid-based Pap test can provide.
|
|
Not all Pap tests are the same. The BD SurePath™ Pap test , FDA-approved liquid-based Pap test offers unique advantages.
|
|
Safe and Effective:
|
- 64.4% increase (p < 0.00001) increase in the detection of HSIL+ lesions1 giving you confidence in finding abnormality.
|
- BD SurePath™ Pap test uses an ethanol-based proprietary preservative that is non-carcinogenic so you don’t have to be concerned with handling or storing the vial.
|
|
Fewer Patient Call Backs:
|
- Proprietary BD SurePath™ Cell Enrichment process reduces obscuring material,enabling a clear view for visualization of diagnostically relevant cells.
|
- Statistically significant reduction in Unsatisfactory cases2, reducing unnecessary and inconvenient repeat testing.
|
|
Less Worry:
|
- Easy-to-use detachable head device(s) ensures 100% of the collected sample is sent to the laboratory for processing, reducing the risk of missing abnormality due to discarding the sample during sample transfer.
|
|
Flexibility:
|
- Up to five slides can be made from the BD SurePath™ cell pellet and the residual patient sample can be retained for additional testing.
|
- Immuno/probe cytology compatible.
|
- Extended sample stability – 4 weeks room temperature,15-30°C and 6 months refrigerated 2-10°C.
|
- Extended shelf-life of 36 months from date of manufacture.
|
|
Click here for more information.
|
BD PrepStain™
Slide Processor
|
 |
|
BD PrepStain™ Slide Processor provides significant advantages for your laboratory.
|
| |
| Safety: |
- The BD SurePath™ process helps ensure chain of custody through barcode labels, scanning and tracking of sample; ensuring same sample from vial-to-slide.
|
- A closed system. Once the vial is sealed by the sample collector, it is never reopened during processing. Unique puncture top BD SurePath™ vial mixes and dispenses without human interaction.
|
- BD SurePath™ preservative has less than 24% Ethanol, is classified as non-hazardous for transport, and is an ideal medium for maintaining cellular morphology.
|
|
Less Worry:
|
- Proprietary BD SurePath™ Cell Enrichment process reduces obscuring material such as blood, mucous and inflammatory cells, enabling a clear view for visualization of diagnostically relevant cells.
|
- Statistically significant reduction in Unsatisfactory cases2.
|
|
Workflow Efficiency:
|
- Walk-away automation that requires less than one-minute per specimen pre-processing time and minimal hands-on Prep Tech labor.
|
- Reduction in staining steps via optional on-board staining.
|
- High throughput processing – 92 slides per hour without staining, 48 slides per hour with staining improving capacity.
|
| Flexibility:
|
- Ample sample volume available, either pre- or post- BD SurePath™ Cell Enrichment; additional slides can be made from the BD SurePath™ cell pellet.
|
- Gynecology and non-gynecology applications to meet all your cytology needs.
|
| Click here for more information. |
BD FocalPoint™
Slide Profiler
|
 |
| The BD FocalPoint™ Slide Profiler provides Intelligent Pap Imaging™ technology to make life easier in the lab.
|
| |
- BD FocalPoint™ Slide Profiler directs cytotechnologist attention to slides most likely to contain abnormality, improving disease detection over manual review1.
|
- Detected numerically more HSIL+ slides as compared to manual review in BD SurePath™ Pap test clinical trials3.
|
- Automated intelligence technology detects morphologic changes and ranks slides based on the probability of an abnormality.
|
- Reduction in false-negatives and false-positives for conventional slides.
|
- High throughput scanning and analysis improves capacity by as much as 33%.
|
- Selects an enriched population of slides for quality control (QC). The QC population of slides is subject to 3 screening events to reduce the potential of false-negatives: BD FocalPoint™ Slide Profiler, cytotechnologist, and directed.
|
- FDA-approved for both BD SurePath™ liquid-based Pap and conventional slides.
|
| Click here for more information. |
BD FocalPoint GS™
Imaging System
|
 |
|
